Oracle Investment Management as of March 31, 2011
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 30 positions in its portfolio as reported in the March 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
WebMD Health | 10.1 | $63B | 1.2M | 53420.00 | |
Thoratec Corporation | 9.7 | $60B | 2.3M | 25930.00 | |
Elan Corporation | 7.7 | $48B | 6.9M | 6880.00 | |
Alexion Pharmaceuticals | 6.8 | $42B | 427k | 98680.00 | |
Acorda Therapeutics | 6.3 | $39B | 1.7M | 23200.00 | |
Quidel Corporation | 6.0 | $37B | 3.1M | 11960.00 | |
MAKO Surgical | 5.0 | $31B | 1.3M | 24120.00 | |
Onyx Pharmaceuticals | 4.7 | $29B | 831k | 35180.00 | |
Masimo Corporation (MASI) | 4.5 | $28B | 837k | 33100.00 | |
Kindred Healthcare | 4.1 | $26B | 1.1M | 23880.00 | |
Health Management Associates | 3.4 | $21B | 1.9M | 10900.00 | |
Opko Health (OPK) | 3.3 | $20B | 5.4M | 3730.00 | |
Hca Holdings (HCA) | 3.2 | $20B | 592k | 33870.00 | |
Skilled Healthcare | 3.2 | $20B | 1.4M | 14390.00 | |
NxStage Medical | 3.0 | $19B | 855k | 21980.00 | |
MAP Pharmaceuticals | 2.6 | $16B | 1.2M | 13790.00 | |
Health Net | 2.6 | $16B | 489k | 32700.00 | |
Gilead Sciences (GILD) | 2.6 | $16B | 375k | 42470.00 | |
LifePoint Hospitals | 2.5 | $15B | 383k | 40197.50 | |
Dex (DXCM) | 2.1 | $13B | 851k | 15520.00 | |
Transition Therapeutics | 1.5 | $9.4B | 2.2M | 4337.10 | |
GTx | 1.5 | $9.3B | 3.6M | 2570.00 | |
Inspire Pharmaceuticals | 1.1 | $6.9B | 1.7M | 3960.00 | |
Pacific Biosciences of California (PACB) | 1.1 | $6.6B | 469k | 14050.00 | |
Emdeon | 0.5 | $3.0B | 188k | 16110.00 | |
Progenics Pharmaceuticals | 0.3 | $2.1B | 333k | 6180.00 | |
Exelixis (EXEL) | 0.3 | $1.7B | 150k | 11330.00 | |
Biogen Idec (BIIB) | 0.1 | $939M | 13k | 73469.99 | |
SIGA Technologies (SIGA) | 0.1 | $908M | 75k | 12100.00 | |
Ladenburg Thalmann Financial Services | 0.0 | $230M | 200k | 1150.00 |